|Description||This test is no longer routinely available. Please contact the Duty Biochemist for further discussion if required Antiarrhythmic drug. Contains dihydroquinidine as an impurity. Metabolised by the liver to several metabolites that are excreted in the urine. Common side effects are not concentration dependent e.g diarrhoea, nausea and vomiting.|
|Indication||Therapeutic drug monitoring|
|Interpretation||Plasma half-life 4-12 hrs.
|Tube||Serum (No Gel)|
|Collection Conditions||Gel separation collection tubes cannot be used. Take sample just prior to next dose.
|Min. Vol||2 mL|
|Freq.||Referred to external laboratory|
|Ref. Range (Male)||3 -7|
|Ref. Range (Female)||3 -7|
|Ref. Range (Paed)|| |
|Ref. Range Notes||3 to 7|
|IP Acute TAT||1 week|
|IP Routine TAT||1 week|
|GP Acute TAT||1 week|
|GP Routine TAT||1 week|
|Turnround Comment||Dr Alun Hutchings:HutchingsAD@cardiff.ac.uk|
Originally edited by : . Review due on 23/11/2018 16:50:56. Published By on 23/11/2017 16:50:56.